Nona Biosciences has enhanced its collaboration with Kelun-Biotech, focusing on the development and licensing of two antibody-drug conjugate (ADC) products. This partnership leverages Nona's H2L2 platform and Harbour Mice® for the discovery and development of therapeutic molecules. The agreement underlines Nona's capability in antibody pharmacological evaluation and their commitment to advancing biopharmaceutical innovations. For detailed information on their progress and technologies, visit www.nonabio.com/en/newsd6.html. . #Biotechnology #AntibodyPharmacology #ADC #Partnership #Innovation